Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia.
Bleeding
fibrinogen
platelet
primary immune thrombocytopenia
thrombocytopenia
Journal
Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117
Informations de publication
Date de publication:
17 Aug 2020
17 Aug 2020
Historique:
pubmed:
16
10
2019
medline:
29
5
2021
entrez:
16
10
2019
Statut:
ppublish
Résumé
Bleeding is the most common clinical symptom and the leading cause of death in patients with primary immune thrombocytopenia (ITP). Our research intends to verify the role of fibrinogen levels as independent determinants of bleeding. We retrospectively analyzed the relationship between fibrinogen levels and bleeding events in 463 patients. Additionally, we confirmed the impact of fibrinogen level on clot firmness in 25 patients via thrombelastography (TEG). Fibrinogen levels (median and inter-quartile range, IQR) were significantly different (
Identifiants
pubmed: 31610686
doi: 10.1080/09537104.2019.1678115
doi:
Substances chimiques
Fibrinogen
9001-32-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM